/Investor DB

Andera Partners — 2022 Investments

8 investments dated 2022 · listed companies and verified rows first · show all

Mineralys Therapeuticsmineralystx.comin𝕏NASDAQ: MLYSSeries B · Jun 2022 · $120M

Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.

BiotechHealthtechRadnor, US

Eric Warren(Chief Commercial Officer)inAlex Gold(Chief Medical Officer)inAdam Levy(Executive Officer)Alexander Asam(Director)

BoardBrian Taylor Slingsby(Founder & former CEO / Board Director)Olivier Litzka(Director)in

Co-investorsHBM Healthcare InvestmentsHBM PartnersSamsara BioCapitalSR One Capital ManagementYsios CapitalAdams Street Partners+3 more

Kyothermkyotherm.cominFeb 2022 · $50M✓ verified

Kyotherm is an investment company that finances decarbonized heat and energy efficiency projects serving industrial, commercial, and public sector actors in Europe and North America.

CleantechClimate TechEnergy

Co-investorsInfraVia Capital PartnersStarquest CapitalBpifrance

HR Pathhr-path.cominMay 2022 · $240M

HR Path provides HR consulting, HRIS integration, and HR outsourcing services, supporting organizations through the digital transformation of their HR departments across the full employee lifecycle.

Enterprise SoftwareHR TechSaaS

François Boulet(Founder)in

Co-investorsArdian

JenaValvejenavalve.comSeries C · Aug 2022 · $100M

JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.

Digital HealthHealthtechMedical DevicesIrvine, US

Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)

BoardArnd Kaltofen(Director)inErik Amble(Director)

Co-investorsBain Capital Life SciencesRosetta Capital Ltd.VI PartnersAtlas VentureGimvInnovatus Capital Partners+5 more

MDxHealthmdxhealth.comin𝕏Aug 2022

MDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases.

BiotechDigital HealthHealthtechMedical DevicesHerstal, US

John Bellano(Chief Commercial Officer of the Issuer.)inRon Kalfus(Chief Financial Officer of the Issuer.)inJoseph Sollee(Executive Officer)Wim Van Criekinge(Chief Scientific Officer)inMichael McGarrity(Chief Executive Officer & Executive Director)Christian Sollee(Executive Vice President of Corporate Development and General Counsel)

Co-investorsOrbiMed

Senstronicsenstronic.cominOct 2022

Senstronic designs and manufactures industrial solutions with a focus on sustainable production practices.

Advanced ManufacturingCleantech

TargED Biopharmaceuticalstargedbiopharmaceuticals.cominSeries A · Feb 2022 · $44M

TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.

BiotechMedical DevicesUtrecht, NL

Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in

Co-investorsBioGeneration VenturesCurie CapitalFund+Hadean VenturesInkefRotrip+1 more

Tubulis GmbHtubulis.comin𝕏Series B · May 2022 · $63Macquired by Gilead Sciences

The page is a placeholder shell showing only cookie/consent notices for embedded third-party content (Vimeo, YouTube, reCAPTCHA, social media) and contains no substantive information about the company.

Dominik Schumacher(Founder)in

Co-investorsAscenta CapitalBayern KapitalBioMedPartnerscoparionFrazier Life SciencesFund++7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.